SCHEMBL8315932

SCHEMBL8315932

O=C(OCc1ccccc1)N1CC=C(c2ccccc2)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.57
KMT2A Q03164 3/20 0.57
GRM5 P41594 1/20 0.57
NPSR1 Q6W5P4 1/20 0.55
ALDH1A1 P00352 5/20 0.53
SMN1; SMN2 Q16637 4/20 0.53
NPC1 O15118 3/20 0.53
RAB9A P51151 3/20 0.53
ALOX15 P16050 2/20 0.53
TSHR P16473 1/20 0.53
LNPEP Q9UIQ6 1/20 0.53
CYP2C19 P33261 1/20 0.51
MAPT P10636 3/20 0.51
KDM4E B2RXH2 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
L3MBTL1 Q9Y468 2/20 0.50
PRMT1 Q99873 1/20 0.49
GAA P10253 2/20 0.49
KCNH2 Q12809 1/20 0.49
HRH3 Q9Y5N1 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL749352 0.93 GRM5 (0.54) MEN1KMT2AGRM5NPSR1ALDH1A1
SCHEMBL15747743 0.91 LNPEP (0.54) MEN1KMT2AGRM5NPSR1ALDH1A1
SCHEMBL22563072 0.91 GRM5 (0.52) MEN1KMT2AGRM5NPSR1ALDH1A1
SCHEMBL10236206 0.91 LNPEP (0.54) MEN1KMT2AGRM5NPSR1ALDH1A1
SCHEMBL2674542 0.89 LNPEP (0.51) MEN1KMT2AGRM5NPSR1ALDH1A1
SCHEMBL21384574 0.89 TDP1 (0.50) MEN1KMT2AGRM5NPSR1ALDH1A1
SCHEMBL5947064 0.88 GRM5 (0.49) MEN1KMT2AGRM5NPSR1ALDH1A1
SCHEMBL6395476 0.87 NPC1 (0.53) GRM5ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL31198721 0.87 GRM5 (0.53) MEN1KMT2AGRM5NPSR1ALDH1A1
SCHEMBL32677104 0.87 GRM5 (0.53) MEN1KMT2AGRM5NPSR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3174881-B1 [1,2,4]TRIAZOLO[4,3-B]PYRIDAZINES FOR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES ASTRAZENECA AB (SE) 2018-03-28 EP disclosed
EP-0630887-B1 4-(aryl-substituted)-piperidines as neurokinin receptor antagonists ZENECA LTD (GB) 1999-07-28 EP disclosed
US-5654299-A TREATING RESPIRATORY SYSTEM DISORDER (I.E. ASTHMA) WITH NEUROKININ 2 RECEPTOR ANTAGONIST ZENECA LIMITED (GB) 1997-08-05 US disclosed
EP-0630887-A1 4-(aryl-substituted)-piperidines as neurokinin receptor antagonists ZENECA LIMITED (GB) 1994-12-28 EP disclosed